Followers | 17 |
Posts | 936 |
Boards Moderated | 0 |
Alias Born | 04/26/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 12, 2018 9:19:59 AM
Scenario A:
1. He can't really say anything about ongoing negotiations and that may include even saying that there are ongoing negotiations. Some enterprising law firm might later sue him for misleading public if the deal falls thru: "We will show that IPIX knew, or at least had notable reasons to believe already on ... that the deal would not be consummated."
2. Nothing worth reporting has happened on other fronts like prurisol trial. Somebody messed up, and re-process is ongoing. I am not certain that Leo knows who, how and when. Even if he knows something about the delay it might be better for IPIX not to pick up a public fight with CRO before the results are in.
Scenario B:
1. There are no negotiations. Interest dried up after suitors took a gander at data. We are left to figure this one out as time goes by.
2. IPIX and it's CROw are furiously figuring out how to put lipstick on a pig formerly known as prurisol trial phase 2b.
ffrol has made some good inferences in support of scenario A. I am with him. BTW, I may have forgotten to welcome you in the world of biopharma investing. After few forays in you stop minding the cases when you burned your ass. Oh, I am lying, it just will hurt less because all scar tissue that is already there. And a 10 bagger is better painkiller than any opioid.
"There's no sense in being precise when you don't even know what you're talking about." John v. Neumann
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM